Navigation Links
DePuy ASR Lawsuit News: Bernstein Liebhard LLP Notes Impending Deadlines for Individuals Who May Want to Participate in DePuy ASR Settlement Program
Date:1/2/2014

o underwent revision surgery to replace the device due to a reason related to the DePuy ASR recall prior to August 31, 2013. Eligible claimants would be entitled to a base award of $250,000. That award could be reduced, however, depending on certain other factors, including their prior medical history. Other circumstances could entitle plaintiffs to a supplemental award if they, for example, required multiple revision surgeries, or if they experience “certain extraordinary injuries” in the future.

According to a report from The New York Times, if the DePuy ASR settlement is accepted by 94% of eligible plaintiffs, it would resolve roughly 8,000 of the 12,000 claims currently pending against Johnson & Johnson and its DePuy Orthopaedics unit. The accord is expected to cost the companies at least $2.5 billion.* According to court documents, ASR recipients who are not eligible to participate in the settlement program may continue to pursue individual lawsuits, as may those who choose to opt out of the settlement program.

Individuals who were affected by the DePuy ASR recall may be eligible to recover for medical bills, lost wages, pain and suffering and more. To learn more about filing a DePuy ASR lawsuit, please visit Bernstein Liebhard LLP’s website, or call 800-511-5092 to arrange for a free, no-obligation case review.

*nytimes.com/2013/11/20/business/johnson-johnson-to-offer-2-5-billion-hip-device-settlement.html, New York Times, November 20, 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. DePuy Hip Settlement News: Rottenstein Law Group LLP Comments on ASR, Pinnacle Mix Up
2. DePuy Metal Hip Implant Lawyer Help: Resource4thePeople Encouraged by Additional Details of Proposed $4 Billion Settlement
3. DePuy ASR Lawsuit Settlement Update: Rottenstein Law Group LLP Comments on New Order Issued in Federal ASR Hip Implant MDL
4. DePuy ASR Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal DePuy ASR Hip Recall Litigation
5. DePuy Hip Settlement News: Number of Federal Pinnacle Cases Now Exceeds 5,000, Rottenstein Law Group LLP Reports
6. DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Order Delaying Consideration of Remand Motions in Federal Pinnacle Hip Litigation
7. DePuy Pinnacle Lawsuit Claims Mount, as Bernstein Liebhard LLP Notes Nearly 6,000 Filings in Federal Pinnacle Hip Litigation
8. DePuy ASR Lawsuit Settlement Update: Rottenstein Law Group LLP Comments on Report of Proposed Additional Compensation
9. DePuy Settlement Update: DePuy Pinnacle Lawsuits Progress in Federal Court, Rottenstein Law Group LLP Reports
10. DePuy ASR Lawsuit Settlement Update: Retired Judge Selected As Claims Administrator, Rottenstein Law Group LLP Reports
11. DePuy ASR™ MDL Lawsuit Update: Settlement Reached in the DePuy ASR™ Hip Implant Multidistrict Litigation (MDL 2197)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... Society for Radiation Oncology (ASTRO) has issued a ... for Endometrial Cancer: An ASTRO Evidence-Based Guideline," that ... the treatment of endometrial cancer. The guideline,s executive ... of Practical Radiation Oncology (PRO), the ... guideline is available as an open-access article online ...
(Date:4/23/2014)... has long been considered to be between 180 and ... used refined microscopic techniques that indicate a much smaller ... tract is only as large as a normal studio ... which passes from the mouth through the esophagus and ... 5 meters in a normal adult, and is built ...
(Date:4/23/2014)... benefits of probiotics, antioxidants and other nutritional compounds, more ... industry is getting in on the action. But legitimate ... the industry is responding with clinical research to shore ... Chemical & Engineering News (C&EN), the weekly ... M. Bomgardner, a senior editor at C&EN, writes that ...
(Date:4/23/2014)... Parents and physicians concerned about an increase in ... can breathe a sigh of relief. According to a ... years worth of data from states with and without ... to increased use among adolescents. The study is published ... of Adolescent Health . , "Any time a ...
(Date:4/23/2014)... Getting to the bottom of Alzheimer,s disease has ... turns and controversies. In the latest crook in ... insight into the interaction between proteins associated with ... journal ACS Chemical Neuroscience , could have ... K. Surewicz, Krzysztof Nieznanski and colleagues explain that ...
Breaking Medicine News(10 mins):Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 3Health News:The surface area of the digestive tract 'only' as large as a studio apartment 2Health News:RI Hospital physician: Legalizing medical marijuana doesn't increase use among adolescents 2
... one of the biggest controversies in fetal surgery and ... medicine physicians// around the world: What's the best way ... most common conditions requiring fetal surgery and the leading ... NIH-funded study on TTTS, conducted at 17 centers in ...
... a gift that brought tears to the receiver and to ... dollars was pledged to the staff at Toronto’s Hospital for Sick ... scion of a beer baron and well-established friend of the hospital. ... Management mutual fund company and his wife Sonia, have pledged this ...
... A child of seven years has succumbed to the flu, in British ... as it usually peaks in the months of December and January. ... say experts. ,According to Dr. Theresa Tam of the Public ... because of influenza and in a bad year that can go up ...
... fewer infection and death rates is announced by the NHS ... tried out successfully in United States. This announcement was received ... ,The incentive scheme initially is set for heart treatments, ... case of very sick patients and severe complications, the hospitals ...
... Cancer is a complex and common disease caused by ... ,Recent research shows that the constitutional mutation in PALB2 ... ,Previous studies have shown that genes are responsible ... of breast cancer. The two major familial breast cancer ...
... Using a unique weaving machine of their design, Duke ... "scaffold" that could greatly improve the ability of physicians ... cells. ,"If further experiments are successful, ... three or four years," said Franklin Moutos, a graduate ...
Cached Medicine News:Health News:Timeliness, a Critical Factor in Treating TTTS 2Health News:Timeliness, a Critical Factor in Treating TTTS 3Health News:Record Donation to Children’s Hospita 2Health News:Flu Strikes Late - Child Succumbs 2Health News:Mutation In PALB2 Elevates Risk of Cancer 2Health News:Woven Cartilage 2
(Date:1/15/2014)... , Jan. 15, 2014 Massachusetts General Hospital ... AMGN ) announced today that they have ... validate new therapeutic targets and develop novel therapies ... that affects millions worldwide. The MGH-Broad-Amgen collaboration brings ...
(Date:1/15/2014)... 2014  Manufacturers, suppliers and distributors of innovative medical-related ... their most important business assets, intellectual property (IP). ... Because of the highly-competitive nature of the ... the most litigious industry sectors of cases involving ...
(Date:1/15/2014)... Inc. (Nasdaq: ECTE ) ("Echo"), a medical ... non-invasive, wireless continuous glucose monitoring system, today announced that ... CEO of Echo Therapeutics, will present at "TEN", Noble ... Mr. Doman will make a corporate presentation to ...
Breaking Medicine Technology:Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Intellectual Property Insurance for Medical-related Products and Services 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
AxSYM Plus provides cutting-edge ergonomics and smart new features that mean increased ease-of-use and enhanced reliability. Also, advanced software means less operator intervention and high-integrit...
The ADx system uses fluorescence polarization immunoassay technology for the detection of abused drugs and toxicology assays....
The UniCel DxI 800 with its exceptional throughput, proven chemiluminescent technology, assay protocols like Access, Access 2, Synchron LXi 725 and load "on-the-fly" capability simplifies and automat...
...
Medicine Products: